Results 131 to 140 of about 43,404 (249)

UV light-mediated corneal crosslinking as (lymph)angioregressive pretreatment to promote graft survival after subsequent high-risk corneal transplantation (CrossCornealVision): protocol for a multicenter, randomized controlled trial

open access: yesTrials
Background Good vision highly depends on the transparency of the cornea, which is the “windscreen” of the eye. In fact, corneal blindness due to transparency loss is the second most common cause of blindness worldwide, and corneal transplantation is the ...
Johanna Wiedemann   +16 more
doaj   +1 more source

Blindness and prognostic factors after trabeculectomy with mitomycin C in patients with open‐angle glaucoma with long‐term follow‐up

open access: yesActa Ophthalmologica, Volume 104, Issue 3, Page e232-e238, May 2026.
Abstract Purpose To determine the long‐term blindness rate and related prognostic factors in eyes with open‐angle glaucoma after trabeculectomy using adjunctive mitomycin C (MMC). Methods The retrospective cohort study included 714 eyes from 714 patients with open angle glaucoma who underwent trabeculectomy using MMC.
Masato Matsuo   +5 more
wiley   +1 more source

Selective Bowman's layer transplantation in the treatment of neurotrophic corneal ulcers

open access: yesIndian Journal of Ophthalmology
The aim of this paper is to present the surgical technique of selective Bowman's layer transplantation as well as the results of the surgery in patients with trophic corneal ulcers.
Diana Wyroślak-Bednarek   +3 more
doaj   +1 more source

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 9, Page 1779-1813, May 2026.
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos   +16 more
wiley   +1 more source

Uptake and early outcomes of a meal replacement intervention in an ethnically diverse adult population living with obesity and significant comorbidity

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 3924-3932, May 2026.
Abstract Aims Structured meal replacement low energy diets (MR‐LED) are effective in obesity management, but evidence for individuals of minority ethnic groups or those with BMI >35 kg/m2 and significant comorbidities is limited. Materials and methods We evaluated the early effectiveness of a weight management program delivered by a multidisciplinary ...
James Shand   +3 more
wiley   +1 more source

Novel Non‐Invasive Treatment for Canine Corneal Ulcers: Application of New Extracellular Matrix‐Based Sticky Sealants

open access: yesVeterinary Ophthalmology, Volume 29, Issue 3, May 2026.
ABSTRACT Objective To evaluate the clinical efficacy of a newly developed adhesive tissue sealant, gelatinized cornea‐derived decellularized extracellular matrix (Cod‐ECM) for the treatment of stromal ulcers in dogs. Animal Studied This study included 60 eyes of 56 dogs diagnosed with stromal ulcerative keratitis, limited to corneal ulcers involving ...
Su‐Jung Yang   +4 more
wiley   +1 more source

Quadruple drug induction therapy in combined renal and pancreas transplantation [PDF]

open access: yes, 1990
Abendroth, D.   +6 more
core   +1 more source

Correction: Clinical manifestations and outcomes of HSK following corneal transplantation. [PDF]

open access: yesFront Med (Lausanne)
Wu D   +16 more
europepmc   +1 more source

Corneal transplantation: A walk to vision. [PDF]

open access: yesMed J Armed Forces India, 2023
Mishra SK   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy